Medicines for Europe supports legal action against provisions in the Urban Wastewater Treatment Directive (UWWTD), which puts access to medicines at risk

Pharma reform brings new opportunities for better regulation, access and security of medicines supply

Harmonising Bioequivalence: Advancing Global Access to Generic Medicines

STADA’s Stephan Eder sets Access, Manufacturing and Sustainability at heart of Medicines for Europe Presidency

Industry Proposes Phased Rollout of ePI for Patient Safety and Environmental Sustainability

Medicines for Europe Statement on Unitary SPC Legislative Process

Joint Industry Statement on EU-Mercosur Negotiations

Council adoption of Urban Waste Water Treatment Directive will generate a tsunami of essential and critical medicine shortages across Europe

New report highlights market access barriers for EU-based generic and biosimilar companies in third countries

Urban Wastewater Treatment Directive risks undoing Europe’s efforts to improve the availability, affordability and accessibility of medicines